Efficiency of a Telemedicine-based Follow-up on for the Medical Management of Patients Leaving the Intensive Care Unit
NCT ID: NCT05542329
Last Updated: 2024-07-18
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
NOT_YET_RECRUITING
NA
448 participants
INTERVENTIONAL
2024-10-31
2027-04-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
In order to meet this need, we propose the implementation of a care chain integrating telemedicine at home. We compare the current system (lack of specific follow-up) to follow-up by telemedicine at home.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Telemedicine Based Remote Home Monitoring After Liver Transplantation
NCT03878329
Feasibility And Efficacy Of Continuous In-Hospital Patient Monitoring
NCT01549717
Staff Acceptance of Remote Patient Monitoring on Intensive Care Unit
NCT03514173
Use of RDS MultiSense® in Post-ICU Patients in the COVID-19 Era
NCT04661423
Better Effectiveness After Transition - Heart Failure
NCT01360203
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Control
Standard of care
No interventions assigned to this group
Tele-Medecine
The experimental group will be given a case of connected devices dedicated to telemedicine allowing them to closely monitor their state of health during the 3 months following discharge from hospital
Monitoring by Tele-Medecine
Monitoring by Tele-Medecine
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Monitoring by Tele-Medecine
Monitoring by Tele-Medecine
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patient admitted to ICU
* Stay in intensive care \> 48h
* Patient having benefited from at least one organ support during the ICU stay: invasive or non-invasive ventilation (including nasal high-flow oxygen therapy), inotropic or vasopressor support, renal replacement therapy)
* Understanding of the French language
* Patient or entourage able to carry out the measures proposed by telemedicine
* Subject affiliated to a social health insurance scheme
* Subject having signed a consent form
Exclusion Criteria
* Pregnancy / lactation
* Voluntary drug poisoning
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University Hospital, Strasbourg, France
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Service de Réanimation Médicale - CH Dijon
Dijon, , France
Service de Réanimation Médicale - CH Mulhouse
Mulhouse, , France
Service de Réanimation Médicale - CHRU Nancy - France
Nancy, , France
Service de Médecine Intensive - Réanimation / CHU Strasbourg - France
Strasbourg, , France
Countries
Review the countries where the study has at least one active or historical site.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Jean-Pierre QUENOT
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
8940
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.